BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2274091)

  • 1. [Significance of monoclonal antibodies in diagnosis and therapy of tumors of the central nervous system].
    Lippitz BE; Kiessling M; Ostertag CB; Bigner DD
    Nervenarzt; 1990 Oct; 61(10):587-96. PubMed ID: 2274091
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monoclonal antibodies in diagnosis of breast cancer].
    Karsten U
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):987-92. PubMed ID: 1776290
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential cytology of effusions using monoclonal antibodies].
    Lüttges J; Neumann K; Pflüger KH; Schmitz-Moormann P
    Pathologe; 1988 May; 9(3):137-42. PubMed ID: 2457213
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor antigens in astrocytic gliomas.
    Kurpad SN; Zhao XG; Wikstrand CJ; Batra SK; McLendon RE; Bigner DD
    Glia; 1995 Nov; 15(3):244-56. PubMed ID: 8586461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities for using monoclonal antibodies in diagnosis and therapy of head and neck cancers. I. Introduction and current state].
    Wustrow TP
    HNO; 1991 Mar; 39(3):82-90. PubMed ID: 2050556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
    Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
    Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
    Lee Y; Bigner DD
    Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
    Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
    Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies: their application in the diagnosis and management of CNS tumors.
    de Tribolet N; Frank E; Mach JP
    Clin Neurosurg; 1988; 34():446-56. PubMed ID: 3288406
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of the colorectal antigen IOR C2.II.
    Vázquez AM; Tormo B; Velandia A; Gómez CA; Alfonso M; Giscombe R; Ansotegui I; Jeddi-Tehrani M; Pérez R; Mellstedt H
    Year Immunol; 1993; 7():137-45. PubMed ID: 7690506
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis and therapy using antibodies as tumor markers].
    Tsukada Y
    Tanpakushitsu Kakusan Koso; 1986 Nov; 31(14):1511-30. PubMed ID: 2433710
    [No Abstract]   [Full Text] [Related]  

  • 13. [Critical study of current tumoral markers].
    Touitou Y; Bogdan A
    Bull Cancer; 1988; 75(3):247-62. PubMed ID: 2453233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential immunohistochemical diagnosis of tumors of the human central nervous system using monoclonal antibodies].
    Vial'tseva IuIu; Bukhvalov IB; Vasilov RG
    Arkh Patol; 1996; 58(2):28-32. PubMed ID: 8712936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts.
    Ostermann E; Garin-Chesa P; Heider KH; Kalat M; Lamche H; Puri C; Kerjaschki D; Rettig WJ; Adolf GR
    Clin Cancer Res; 2008 Jul; 14(14):4584-92. PubMed ID: 18628473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results on the use of Ca 15-3 in malignant ovarian pathology.
    Ferdeghini M; Gadducci A; Romagnoli S; Bartolini T; Facchini V; Scatena P; Bianchi R; Fioretti P
    J Nucl Med Allied Sci; 1987; 31(4):299-302. PubMed ID: 3481812
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution of monoclonal antibodies within the framework of urothelial tumors of the bladder].
    Chopin DK
    Pathol Biol (Paris); 1988 Apr; 36(4):301-8. PubMed ID: 3287299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HEA 125 and Ber EP4: two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors.
    Gottschalk J; Jautzke G; Zimmer C; Cervós-Navarro J
    Clin Neuropathol; 1993; 12(2):68-72. PubMed ID: 7682900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytodiagnosis with monoclonal antibodies.
    Ax W
    Behring Inst Mitt; 1988 Apr; (82):174-81. PubMed ID: 3408452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.